Bullish on Lupin, Aurobindo: Amisha Vora

In a chat with ET Now, Amisha Vora, Joint MD, Prabhudas Lilladher, shares her views on pharma sector.

ET Now: Likewise for pharma because suddenly it seems like that sector has fallen off favour, would you still be looking at opportunities there at this point or just completely avoid the space?

Amisha Vora: We continue to be selectively bullish on a few stocks like Lupin, Aurobindo and maybe a couple of more and we will continue to maintain that stance.

We think that one will not increase the weightage in that sector because more than IT, rupee depreciation has benefitted the pharma in terms of the margins.

So, even there the leverage in terms of margin expansion because of rupee seems to have gone away but selective stocks where there are some major product upsides will continue to do still well but they will not be ones as sectors which one will chase or keep overweight in hurry in their portfolio.